HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal toxicity of propamidine.

Abstract
Two patients with Acanthamoeba keratitis developed a corneal abnormality following prolonged treatment with topical 0.1% [corrected] propamidine isethionate. In both instances, withdrawal of drug therapy resulted in a gradual clearing of the keratopathy, with no permanent sequelae. The changes we observed may be confused with those of active Acanthamoeba infection.
AuthorsK J Johns, W S Head, D M O'Day
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 106 Issue 1 Pg. 68-9 (Jan 1988) ISSN: 0003-9950 [Print] United States
PMID3337709 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Amidines
  • Benzamidines
  • propamidine isethionate
Topics
  • Acanthamoeba
  • Administration, Topical
  • Adult
  • Amebiasis (drug therapy)
  • Amidines (adverse effects)
  • Animals
  • Benzamidines (administration & dosage, adverse effects, therapeutic use)
  • Corneal Diseases (chemically induced, pathology)
  • Cysts (chemically induced)
  • Female
  • Humans
  • Keratitis (etiology)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: